Global /Indonesia /Healthcare /Medical Care Facilities /DGNS

PT Diagnos Laboratorium Utama Tbk

DGNS

• IDX: DGNS • Delayed

266.00IDR -4.3%

0.0149 USD

As of 11 June 2026, PT Diagnos Laboratorium Utama Tbk has a market cap of $19.42M USD, ranking #37258 globally and #676 in Indonesia. It ranks #3343 in the Healthcare sector, and #403 in the Medical Care Facilities industry.

Global Rank

37258

Country Rank

676

Sector Rank

3343

Industry Rank

403

Key Stats

Market Cap

$19.42MUSD

347.5B IDR

Enterprise Value

$23.17MUSD

414.71B IDR

Revenue (TTM)

$9.31MUSD

166.62B IDR

EBITDA (TTM)

$833.2KUSD

14.91B IDR

Net Income (TTM)

$164.12KUSD

2.94B IDR

EBITDA Margin

8.9%

Profit Margin

1.8%

PE Ratio

118.3

PS Ratio

2.1

PB Ratio

1.7

EV/EBITDA

24.2

Company Profile

Country (HQ)

Indonesia

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Fergus Richard open_in_new

Employees

111

Founded

2007

Website

diagnos.co.id open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-4.3%	-1.4%	-6.7%	-6.7%	87%	51%	64%	17%	-52%

News

Markets

Exchange	Ticker	Price	Quotes
Indonesia Stock Exchange (IDX) MIC: XIDX PRIMARY	DGNS PT Diagnos Laboratorium Utama Tbk Ordinary Shares ISIN: ID1000158702 Shares Out.: Shares Outstanding: 1.375B¹ Shares Float: 275.0M² TV: TradingView: IDX: DGNS SA: Stock Analysis: IDX: DGNS YF: Yahoo Finance: DGNS.JK GF: Google Finance: IDX: DGNS BA: Barron's: DGNS MS: Morningstar: XIDX: DGNS	266.00 IDR	TV: TradingView: IDX: DGNS SA: Stock Analysis: IDX: DGNS YF: Yahoo Finance: DGNS.JK GF: Google Finance: IDX: DGNS BA: Barron's: DGNS MS: Morningstar: XIDX: DGNS

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About PT Diagnos Laboratorium Utama Tbk

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers laboratory tests comprising hemostasis, hepatitis, autoimmune and rheumatology, tumor markers, toxicology, lipid, allergies, TORCH, diabetes, electrolytes-blood gases, respiratory tract infection, pathology anatomy, neonatal screening, hematology, body fluids, feces, specific proteins, DNAnswer genomics, kidney function, liver function, immunology, osteoporosis, thyroid, pharmacogenomic, heart, reproduction and fertility, microbiology, drug monitoring, lungs, gastrointestinal, nutrition and heavy metals, anemia and other bacteria; genomics, homecare services; and inspection panel tests. It also provides doctor consultation; clinic services; corporate health services. PT Diagnos Laboratorium Utama Tbk was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.

Similar Companies

Industry: Medical Care Facilities (Indonesia)

Name	Market Cap (USD) diff.	PE	Country
PT Sejahteraraya Anugrahjaya Tbk IDX: SRAJ	$10.18B 182.11T IDR 52K%	-	Indonesia
PT Siloam International Hospitals Tbk IDX: SILO	$1.83B 32.73T IDR 9K%	29.4	Indonesia
PT Mitra Keluarga Karyasehat Tbk IDX: MIKA	$1.51B 26.98T IDR 8K%	19.8	Indonesia
PT Medikaloka Hermina Tbk IDX: HEAL	$1.0B 17.98T IDR 5K%	41.2	Indonesia
PT Metro Healthcare Indonesia Tbk IDX: CARE	$758.03M 13.57T IDR 4K%	2739.1	Indonesia
PT Famon Awal Bros Sedaya Tbk IDX: PRAY	$581.11M 10.4T IDR 3K%	49.2	Indonesia

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.18B 852.82B AED 1M%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 498K%	14.9	United States
Fresenius SE & Co. KGaA XETRA: FRE	$26.54B 22.97B EUR 137K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.44B 22.02B EUR 131K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.49B 84.42B SAR 116K%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 109K%	24.6	United States

chevron_leftBack